Partial and weak oestrogenicity of the red wine constituent resveratrol: consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects.
about
Effects of p-nonylphenol and resveratrol on body and organ weight and in vivo fertility of outbred CD-1 miceIncreasing the sensitivity of the rodent uterotrophic assay to estrogens, with particular reference to bisphenol A.Confirmation of uterotrophic activity of 3-(4-methylbenzylidine)camphor in the immature ratRoles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer MetastasisProperties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and HumansResveratrol modulates the inflammatory response via an estrogen receptor-signal integration networkPhytoestrogens and breast cancer prevention: possible mechanisms of actionPolyphyenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells.Quercetin, a phytoestrogen and dietary flavonoid, activates different membrane-bound guanylate cyclase isoforms in LLC-PK1 and PC12 cells.Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha.Significance of wine and resveratrol in cardiovascular disease: French paradox revisitedResveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanismsPhytoestrogens: food or drug?PTEN mediates the antioxidant effect of resveratrol at nutritionally relevant concentrations.Chemoprevention in experimental animals.DNA microarray-based gene expression profiling of estrogenic chemicals.Wine and bone health: a review.Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells.Safety of synthetic trans-resveratrol as a novel food pursuant to Regulation (EC) No 258/97
P2860
Q24798112-226B0582-ED53-4803-B482-548C8835F5FAQ24813465-668B24DA-4C25-49C2-B83C-23113CF3D553Q24816587-FD987D7F-BFE9-4129-991C-09109642561AQ26745561-A404F1E6-9B82-430C-B99C-45C432FBC232Q26801926-78C244E6-9985-4952-B3DF-5E09561B9E28Q27683572-6A42D122-022F-4A8D-A83F-B1C12A358D99Q28276620-7CB58E0C-77B5-498D-B856-34B7008867B4Q32117355-2D6E1B99-8968-4859-B5A5-FD7E32BD60B8Q33965742-B9541E8E-6545-45F6-846E-3013D62D9DA9Q35026250-1B924A86-45EF-488F-8A2D-2A6A8F43E977Q36511645-7592D007-2E22-439D-9F82-C441D17784A7Q36938449-B75E296B-B0F3-4289-BD91-1FA2AD19BF0CQ37430472-9B32DF76-CD75-4881-9472-483441B814A7Q37725464-54A8E137-52C7-4E43-A267-8F25A9FE058BQ37831932-D0429F28-6DB6-4BCD-88F3-BA38489B74E7Q38176554-773FFBAF-2A4B-413E-B506-B0382E5E35E2Q38400055-BA0E17B2-5CC7-40B8-9A8E-9EB4980F9D92Q40847302-F2BA07F4-86CA-40D5-A1D6-3823CAFD70FEQ47157595-BB260E62-902F-48DD-8479-810A6D5FBC42
P2860
Partial and weak oestrogenicity of the red wine constituent resveratrol: consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Partial and weak oestrogenicit ...... iovascular protective effects.
@en
type
label
Partial and weak oestrogenicit ...... iovascular protective effects.
@en
prefLabel
Partial and weak oestrogenicit ...... iovascular protective effects.
@en
P2093
P2860
P1476
Partial and weak oestrogenicit ...... iovascular protective effects.
@en
P2093
A N Brooks
J P Sumpter
N Beresford
P A Lefevre
P2860
P356
10.1002/(SICI)1099-1263(199901/02)19:1<39::AID-JAT534>3.0.CO;2-M
P407
P577
1999-01-01T00:00:00Z